XTRA:GXILife Sciences
Could Gerresheimer (XTRA:GXI) Leverage FDA-Approved Home-Infusion Device to Strengthen its Medtech Differentiation?
On October 13, 2025, SQ Innovation announced that the US FDA had granted approval for Lasix ONYU, a combination product for edema in congestive heart failure, which features Gerresheimer’s on-body infusor device for at-home subcutaneous drug delivery.
This milestone showcases Gerresheimer’s advanced expertise in drug delivery technology and its integral role as a full-service partner in the rapidly evolving medtech space.
We will examine how FDA approval of a home-infusion device may...